Neuropro Therapeutics
Yachats, US
Biotech
Founders & leadership
DW
Daryl W. HochmanExecutive Officer, Director
LW
Louis W. SerafiniDirector
LW
Luciano W. CacioppoDirector
Reported raises · per SEC filings
Form D private placements$5.1MraisedApr 2023 · 2 investors · Biotechnology
Rule 506(b)$215.9KraisedDec 2016 · 4 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.